Drawing for OSLER ORIGIN

USPTO serial 79337412

OSLER ORIGIN

Reviewed by CopyMark Law Group

Reg. 7134978Status 700Registered
Filing date
Status date
Registration date
Aug 15, 2023
Examiner
MATZINGER, AMY L
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with OSLER ORIGIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Eric Lamb

Eric Lamb Frost Brown Todd LLP111 Monument Circle, Suite 4500Indianapolis, IN 46204United States

Goods and services

ClassDescriptionStatusFirst use
001Assays and reagents for scientific or medical research purposesACTIVE—
005Pharmaceutical preparations for the treatment of acute and chronic diseases, infectious diseases, hereditary diseases, dietary and metabolic deficiency disorders, and physiological disorders; medical preparations for the treatment of acute and chronic diseases, infectious diseases, hereditary diseases, dietary and metabolic deficiency disorders, and physiological disorders; chemical preparations for medical purposes, namely for the treatment of acute and chronic diseases, infectious diseases, hereditary diseases, dietary and metabolic deficiency disorders, and physiological disorders; chemical reagents for medical use; diagnostic preparations, substances, agents, reagents and assays for medical purposes; diagnostic testing preparations, substances, agents, reagents and assays for medical purposes, namely, for testing blood, body fluids, blood derivatives and body fluids derivativesACTIVE—
009Scientific apparatus and instruments, namely, devices for collecting, storing, processing, transferring, testing, analysing and monitoring liquid samples, blood, body fluids, blood derivatives and body fluid derivatives; scientific research and laboratory apparatus and instruments, namely, diagnostic devices for detecting pathogens and biomarkers in blood, body fluids, blood derivatives and body fluid derivatives for clinical research and scientific purposes; material testing apparatus and instruments, namely, analysers and cartridges for testing chemical, biological and environmental samples for clinical research and scientific purposes; apparatus and instruments for transmission of communication; monitoring, measuring, signalling and control apparatus and instruments, namely, electronic measuring instruments for use in electrochemical analysis, potentiostats, galvanostats and impedance analyzers; audio-visual receivers; computer apparatus and instruments, namely, computer hardware and peripheral apparatus for clinical research and scientific purposes; downloadable computer software for operating analytical and diagnostic devices for clinical research purposes and for scientific, veterinary and medical purposes; downloadable computer application software for management of patient data, healthcare workflow and connectivity between patients and healthcare providers; integrated computerized system for data capture, collection, recording, processing, transmission, reproduction, storage and/or communications; parts and fittings for all the aforementioned goodsACTIVE—
010Medical apparatus and instruments, namely, wearable devices for patient vital signs, blood and sweat properties and physical movement monitoring, and devices for collecting, storing, processing, transferring, testing, analysing and monitoring liquid samples, blood, body fluids, blood derivatives and body fluid derivatives for medical purposes; medical diagnostic apparatus and instruments, namely, diagnostic devices for detecting pathogens and biomarkers in blood, body fluids, blood derivatives and body fluid derivatives and reporting in relation to the same; testing apparatus and instruments for medical and/or medical diagnostic purposes, namely, analysers and cartridges for use in diagnosing and/or monitoring acute and chronic diseases, infectious diseases, hereditary diseases, dietary and metabolic deficiency disorders, and physiological disorders; medical diagnostic testing apparatus and instruments for the measurement of clinical biomarkers; parts and fittings for all the aforementioned goodsACTIVE—
025Clothing, namely, shirts, pants, coats, coveralls, dresses and jackets; footwear; headgear namely hats, caps as clothing, and headwearACTIVE—
041Education services, namely, providing seminars, non-downloadable webinars, conferences and classes about clinical research, science, medical and veterinary diagnostics, patient health and wellbeing; training services in the field of clinical research, science, medical and veterinary diagnostics, patient health and wellbeing; research in the field of education; publishing services of books, electronic books, guides, workbooks, newsletters, manuals and brochures; publishing services, namely publishing of veterinary publications; publication of medical and/or scientific publications; consultancy, advisory and information services relating to or connected with the aforementioned servicesACTIVE—
042Research and development of new products for others; medical research and development services; scientific research and development services; pharmaceutical research and development services; new product design services; design of research, scientific and diagnostic apparatus and instrument products for others; design of new products, namely, pharmaceutical preparations; design of new products, namely, veterinary preparations; design of new products, namely, diagnostic preparations, substances, agents, reagents, and assays; research, design and development of medical apparatus and instrument products; research, design and development of medical diagnostic apparatus and instrument products; research, design and development of diagnostic test products for the measurement of clinical biomarkers; software research, design and development services; consultancy, advisory and information services relating to or connected with the aforementioned servicesACTIVE—
044Medical services; medical diagnostic testing, analysing, monitoring and reporting services; medical testing, screening and analysis services relating to the diagnosis and/or treatment of disease, namely acute and chronic diseases, infectious diseases, hereditary diseases, dietary disorders, metabolic deficiency disorders, and physiological disorders; consultancy, advisory and information services relating to or connected with the aforementioned servicesACTIVE—
045Intellectual property licensing services; licensing of technology products and software; licensing of manufacturing technology products, software and manufacturing processes; licensing of intellectual property and/or intellectual property rights; licensing of industrial property products, software and industrial property rights; licensing of patents, confidential information, technical information and know-how; consultancy, advisory and information services relating to or connected with the aforementioned servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 11, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 16, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 16, 2023FIMPFINAL DISPOSITION PROCESSED—
Nov 15, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 8, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 8, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 8, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 2, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 15, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 15, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 30, 2023GPNXNOTIFICATION PROCESSED BY IB—
May 30, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 30, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 10, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 10, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 10, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 24, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 20, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Apr 20, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 20, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 20, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 23, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 23, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 23, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 8, 2022RFNTREFUSAL PROCESSED BY IB—
Oct 15, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 15, 2022RFRRREFUSAL PROCESSED BY MPU—
Aug 26, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 25, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 22, 2022DOCKASSIGNED TO EXAMINER—
Apr 12, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 8, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 7, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance